Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonati

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Blood|October 15, 1996
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genisteinC Carlo-Stella, G Dotti, L Mangoni, et al.
Cancer Research|February 17, 2000
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemiasA Bonati, C Carlo-Stella, P Lunghi, et al.
Journal of Inorganic Biochemistry|April 1, 1997
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activityM C Rodriguez-Argüelles, M Belicchi Ferrari, G Gasparri Fava, et al.
Journal of Inorganic Biochemistry|December 22, 1999
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligandsJ S Casas, A Castiñeiras, M C Rodríguez-Argüelles, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Leukemia|March 14, 2008
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemiaL S Steelman, S L Abrams, J Whelan, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Blood|October 15, 1996
Selection of myeloid progenitors lacking BCR/ABL mRNA in chronic myelogenous leukemia patients after in vitro treatment with the tyrosine kinase inhibitor genisteinC Carlo-Stella, G Dotti, L Mangoni, et al.
Cancer Research|February 17, 2000
Selective expression and constitutive phosphorylation of SHC proteins [corrected] in the CD34+ fraction of chronic myelogenous leukemiasA Bonati, C Carlo-Stella, P Lunghi, et al.
Journal of Inorganic Biochemistry|April 1, 1997
Acenaphthenequinone thiosemicarbazone and its transition metal complexes: synthesis, structure, and biological activityM C Rodriguez-Argüelles, M Belicchi Ferrari, G Gasparri Fava, et al.
Journal of Inorganic Biochemistry|December 22, 1999
Synthesis, structure, spectroscopic properties and biological activity of mixed diorganotin(IV) complexes containing pyridine-2-carbaldehyde thiosemicarbazonato and diphenyldithiophosphinato ligandsJ S Casas, A Castiñeiras, M C Rodríguez-Argüelles, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Leukemia|March 14, 2008
Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemiaL S Steelman, S L Abrams, J Whelan, et al.
Pageof 7